Continuum Advisory, LLC Abb Vie Inc. Transaction History
Continuum Advisory, LLC
- $778 Million
- Q3 2024
A detailed history of Continuum Advisory, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Continuum Advisory, LLC holds 14,309 shares of ABBV stock, worth $2.59 Million. This represents 0.36% of its overall portfolio holdings.
Number of Shares
14,309
Previous 13,705
4.41%
Holding current value
$2.59 Million
Previous $2.35 Million
20.21%
% of portfolio
0.36%
Previous 0.35%
Shares
28 transactions
Others Institutions Holding ABBV
# of Institutions
3,854Shares Held
1.25BCall Options Held
16.8MPut Options Held
12.2M-
Vanguard Group Inc Valley Forge, PA172MShares$31.1 Billion0.62% of portfolio
-
Black Rock Inc. New York, NY136MShares$24.7 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.1MShares$14.3 Billion0.65% of portfolio
-
Jpmorgan Chase & CO New York, NY52.3MShares$9.48 Billion0.85% of portfolio
-
Morgan Stanley New York, NY38.7MShares$7.02 Billion0.56% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $320B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...